ABIGAIL ROSS: Open Payments
NPI 1043918303 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 11 payments from 2 companies in 2025. Trend: 2023 $574 · 2024 $735 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $275 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $96 |
Products named: Livdelzi, XIFAXAN.
Industry payments across PA — which companies pay providers there.
